Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates
09:21am, Thursday, 08'th Aug 2024
AxoGen (AXGN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to loss of $0.03 per share a year ago.
Axogen, Inc. Announces New Leadership Appointments
07:05am, Thursday, 08'th Aug 2024
ALACHUA, Fla. and TAMPA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Thursday, 01'st Aug 2024
AxoGen (AXGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
07:00am, Tuesday, 23'rd Jul 2024
ALACHUA and TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today a
AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?
09:41am, Friday, 12'th Jul 2024
AxoGen (AXGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
07:00am, Monday, 01'st Jul 2024
ALACHUA, Fla. and TAMPA, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, a
AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection
01:55pm, Tuesday, 25'th Jun 2024
AxoGen (AXGN) announces the full launch of its Avive+ Soft Tissue Matrix to provide comprehensive solutions for nerve protection.
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
07:00am, Monday, 24'th Jun 2024
ALACHUA, Fla. and TAMPA, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, a
Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
06:01am, Wednesday, 12'th Jun 2024
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
04:30pm, Tuesday, 28'th May 2024
Showcasing Axogen's Dedication to Fueling Ohio's Biotechnology Sector Growth Showcasing Axogen's Dedication to Fueling Ohio's Biotechnology Sector Growth
AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
01:31pm, Friday, 17'th May 2024
AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.
AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript
01:21am, Sunday, 05'th May 2024
AxoGen, Inc. (NASDAQ:AXGN ) Q1 2024 Earnings Conference Call May 2, 2024 8:00 AM ET Company Participants Harold Tamayo - VP, Finance and IR Karen Zaderej - Chairman, CEO and President Nir Naor - CFO C
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
09:16am, Thursday, 02'nd May 2024
AxoGen (AXGN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.10 per share a year ago.
Axogen, Inc Reports First Quarter 2024 Financial Results
07:00am, Thursday, 02'nd May 2024
ALACHUA, Fla. and TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, to
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
04:50pm, Monday, 29'th Apr 2024
ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
